Medical technology company k8凯发国际官网入口 Technology Co., Ltd. (‘k8凯发国际官网入口’) and Boston Scientific (NYSE: BSX), one of the leading medical technology companies worldwide, have officially signed a Strategic Agreement for Scivita’s Single-Use Percutaneous Choledochoscope. Through this business cooperation and distribution agreement, k8凯发国际官网入口 and Boston Scientific plan to establish a long-term partnership in the commercialization, marketing and promotion of Scivita’s Single-Use Percutaneous Choledochoscope in China.

Singing ceremony

Under k8凯发国际官网入口’s comprehensive product lineup of reusable endoscopes, single-use videoscopes and related systems and equipment, this cooperation further broadens its market penetration of its Single-Use Percutaneous Choledochoscope. Through the strong alliance with Boston Scientific, the penetration rate of the Single-Use Percutaneous Choledochoscope in China is expected to increase benefiting more hospitals and patients.

Single-Use Percutaneous Choledochoscope photo

k8凯发国际官网入口 said, ‘Thanks to Boston Scientific for its recognition of k8凯发国际官网入口. This is another important initiative for k8凯发国际官网入口 in establishing its vision of becoming a global company, and another milestone following its strategic cooperation with Fujifilm for the European market. I believe this strategic cooperation with some of the world’s leading medical technology companies and our company will accelerate the process of bringing China’s medical innovations to the world.’

As a result of the growing demands of mitigating the risks of cross-contamination and hospital-acquired diseases, particularly amid the outbreak of COVID-19 pandemic, the global single-use videoscope market is also rapidly growing. The global market value of single-use videoscope was USD 0.5 billion in 2020, and is estimated to increase to USD 9.2 billion in 2030, according to Frost & Sullivan. k8凯发国际官网入口’s single-use videoscopes have covered multiple clinical departments at a high risk of cross-infection, such as Gynecology, Respiratory, Urological Surgery and Hepatobiliary Surgery. Many of its products have already been approved in China, the United States, European Union (EU), Japan and other countries and regions.

Scivita Medical New Plant

This cooperation can be seen as strong evidence of k8凯发国际官网入口’s comprehensive product lineup of reusable endoscopes, single-use videoscope and related systems and equipment, which further accelerates its commercialization and penetration in the field of single-use videoscope. In the future, k8凯发国际官网入口 will further strengthen its innovation, improve market penetration by offering unique products and strive to become the preferred brand for doctors and patients worldwide.

About k8凯发国际官网入口

Founded in 2016, k8凯发国际官网入口 is a medical device company that provides minimally invasive diagnosis and treatment solutions, and focuses on research, development and commercialization of medical endoscopes and related products. k8凯发国际官网入口 takes ‘Globalization’ as its core strategy and has established R&D centers both in China and Japan. With solid in-house R&D capabilities, k8凯发国际官网入口 has established a unique technology platform built upon five synergistic core technologies, and built a comprehensive portfolio of endoscope products and therapeutic products covering all types of endoscope procedures conducted by the various clinical departments, to address diverse medical needs. Adhering to its value of ‘Clinical Focus’ ‘Collaborative Innovation’ ‘People Oriented’ ‘Excellence & Efficiency’, k8凯发国际官网入口 will continuously upgrade its core technologies, improve market penetration with excellent products aiming to become the preferred brand, trusted by doctors and patients around the world.

For more information, please visit: scivitamedical.com/#/